Table 4.
Estimated DCERs for increasing annual screening to biennial screening by HbA1c level and duration of diabetes
| HbA1c level mmol/mol (%) | Duration of diabetes (years) | ||||||
|---|---|---|---|---|---|---|---|
| 48 (6.5) | 64 (8.0) | 72 (8.7)a | 80 (9.5) | < 6 | 6–12 | > 12 | |
| T1DM (DCER QALY £) | 94,696c | 37,646c | 23,446c | 11,089 | 83,856c | 23,446 | 13,340 |
| HbA1c level mmol/mol (%) | Duration of diabetes (years) | ||||||
|---|---|---|---|---|---|---|---|
| 48 (6.5) | 58.8 (7.5)b | 64 (8.0) | 80 (9.5) | < 3 | 3–6 | > 6 | |
| T2DM (DCER QALY £) | 106,075c | 71,243c | 58,653c | 31,626c | 87,405c | 71,243c | 54,106c |
aMean HbA1c value for the population with T1DM
bMean HbA1c value for the population with T2DM
cChanging to biennial screening ICER considered cost effective at above £20,000 per QALY lost threshold